ACT
Price
$44.18Alerts
Change
-$0.01 (-0.02%)
Updated
Nov 20 closing price
Capitalization
6.38B
80 days until earnings call
Intraday BUY SELL Signals
AMSF
Price
$18.87Alerts
Change
-$0.03 (-0.16%)
Updated
Nov 20 closing price
Capitalization
363.12M
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACT vs AMSF

ACT vs AMSF Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACT vs. AMSF commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACT is a Hold and AMSF is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACT with price predictions
Nov 20, 2026

ACT sees MACD Histogram crosses below signal line

ACT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 09, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 30 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACT as a result. In 50 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

ACT moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACT crossed bearishly below the 50-day moving average on November 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 33%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

ACT broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACT advanced for three days, in 215 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 114 of 237 cases where ACT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 48%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. ACT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.183) is normal, around the industry mean (0.987). P/E Ratio (9.734) is within average values for comparable stocks, (11.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.944). Dividend Yield (0.021) settles around the average of (0.486) among similar stocks. ACT's P/S Ratio (5.627) is slightly higher than the industry average of (2.529).

A.I.Advisor
a Summary for AMSF with price predictions
Nov 20, 2026

AMSF sees MACD Histogram just turned negative

AMSF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 27 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMSF as a result. In 53 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.

AMSF moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMSF crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMSF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for AMSF entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMSF advanced for three days, in 166 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

AMSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.453) is normal, around the industry mean (0.987). P/E Ratio (7.836) is within average values for comparable stocks, (11.360). AMSF's Projected Growth (PEG Ratio) (2.410) is slightly higher than the industry average of (0.944). Dividend Yield (0.084) settles around the average of (0.486) among similar stocks. P/S Ratio (1.394) is also within normal values, averaging (2.529).

The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. AMSF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock worse than average.

FUNDAMENTALS RATINGS
ACT vs AMSF: Fundamental Ratings
ACT
AMSF
OUTLOOK RATING
1..100
5754
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
3100
SMR RATING
1..100
8049
PRICE GROWTH RATING
1..100
5581
P/E GROWTH RATING
1..100
3091
SEASONALITY SCORE
1..100
30n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMSF's Valuation (43) in the Life Or Health Insurance industry is somewhat better than the same rating for ACT (87) in the null industry. This means that AMSF’s stock grew somewhat faster than ACT’s over the last 12 months.

ACT's Profit vs Risk Rating (3) in the null industry is significantly better than the same rating for AMSF (100) in the Life Or Health Insurance industry. This means that ACT’s stock grew significantly faster than AMSF’s over the last 12 months.

AMSF's SMR Rating (49) in the Life Or Health Insurance industry is in the same range as ACT (80) in the null industry. This means that AMSF’s stock grew similarly to ACT’s over the last 12 months.

ACT's Price Growth Rating (55) in the null industry is in the same range as AMSF (81) in the Life Or Health Insurance industry. This means that ACT’s stock grew similarly to AMSF’s over the last 12 months.

ACT's P/E Growth Rating (30) in the null industry is somewhat better than the same rating for AMSF (91) in the Life Or Health Insurance industry. This means that ACT’s stock grew somewhat faster than AMSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACTAMSF
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 27 days ago
61%
Bullish Trend 6 days ago
56%
Declines
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
54%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (ACT: $44.18 vs. AMSF: $18.87)
Brand notoriety: ACT and AMSF are both not notable
Both companies represent the Specialty Insurance industry
Current volume relative to the 65-day Moving Average: ACT: 91% vs. AMSF: 63%
Market capitalization -- ACT: $6.38B vs. AMSF: $363.12M
ACT [@Specialty Insurance] is valued at $6.38B. AMSF’s [@Specialty Insurance] market capitalization is $363.12M. The market cap for tickers in the [@Specialty Insurance] industry ranges from $2.22M to $11.76B. The average market capitalization across the [@Specialty Insurance] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACT’s FA Score shows that 2 FA rating(s) are green while AMSF’s FA Score has 0 green FA rating(s).

  • ACT’s FA Score: 2 green, 3 red.
  • AMSF’s FA Score: 0 green, 5 red.
According to our system of comparison, ACT is a better buy in the long-term than AMSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACT’s TA Score shows that 4 TA indicator(s) are bullish while AMSF’s TA Score has 4 bullish TA indicator(s).

  • ACT’s TA Score: 4 bullish, 6 bearish.
  • AMSF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AMSF is a better buy in the short-term than ACT.

Price Growth

ACT (@Specialty Insurance) experienced а -2.67% price change this week, while AMSF (@Specialty Insurance) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Specialty Insurance industry was -3.11%. For the same industry, the average monthly price growth was -4.31%, and the average quarterly price growth was -5.82%.

Reported Earning Dates

ACT is expected to report earnings on Feb 09, 2027.

AMSF is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Specialty Insurance (-3.11% weekly)

Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.

View a ticker or compare two or three
Interact to see
Advertisement

ACT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACT has been closely correlated with NMIH. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACT jumps, then NMIH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACT
1D Price
Change %
ACT100%
-0.02%
NMIH - ACT
80%
Closely correlated
+0.47%
ESNT - ACT
79%
Closely correlated
+0.99%
MTG - ACT
78%
Closely correlated
-0.04%
RDN - ACT
67%
Closely correlated
+1.04%
AIZ - ACT
58%
Loosely correlated
+0.20%
More

AMSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMSF has been loosely correlated with AIZ. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AMSF jumps, then AIZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMSF
1D Price
Change %
AMSF100%
-0.16%
AIZ - AMSF
50%
Loosely correlated
+0.20%
ITIC - AMSF
38%
Loosely correlated
-0.64%
AXS - AMSF
36%
Loosely correlated
+0.49%
RYAN - AMSF
36%
Loosely correlated
+1.01%
ACT - AMSF
30%
Poorly correlated
-0.02%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZOCT27.70-0.14
-0.50%
Innovator 1 Yr October (ZOCT)
NUDM36.50-0.99
-2.65%
Nuveen ESG International Developed Markets Equity ETF (NUDM)
VEU73.78-2.52
-3.30%
Vanguard FTSE All-World ex-US Index Fund (VEU)
ARWG22.64-0.93
-3.93%
Archer Growth ETF (ARWG)
TSLR14.03-2.50
-15.12%
GraniteShares 2x Long TSLA Daily ETF (TSLR)